Published in J Med Genet on June 18, 2009
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet (2013) 2.44
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol (2013) 2.41
Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology (2011) 1.75
Emerging topics in FXTAS. J Neurodev Disord (2014) 1.47
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 1.44
Progressive spatial processing deficits in a mouse model of the fragile X premutation. Behav Neurosci (2009) 1.28
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. Future Neurol (2009) 1.17
Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology (2012) 0.96
Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex (2012) 0.90
Cognitive abilities on transitive inference using a novel touchscreen technology for mice. Cereb Cortex (2013) 0.87
EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet (2014) 0.86
Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2014) 0.86
Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology. Aging Ment Health (2010) 0.85
Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol (2012) 0.84
Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency. Eur J Hum Genet (2011) 0.83
Young adult male carriers of the fragile X premutation exhibit genetically modulated impairments in visuospatial tasks controlled for psychomotor speed. J Neurodev Disord (2012) 0.83
Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology (2011) 0.81
Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disord Ther (2014) 0.81
COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS. Curr Psychiatry Rev (2013) 0.79
Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers. Future Neurol (2014) 0.78
Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. Clin Neuropsychol (2016) 0.77
Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol (2016) 0.77
Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS. Neuropsychology (2014) 0.77
Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome. J Geriatr Psychiatry Neurol (2016) 0.75
Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome. Intractable Rare Dis Res (2014) 0.75
A cross-sectional analysis of orienting of visuospatial attention in child and adult carriers of the fragile X premutation. J Neurodev Disord (2014) 0.75
A gene map of the human genome. Science (1996) 14.32
A physical map of 30,000 human genes. Science (1998) 12.43
Detection of bacteriuria by luciferase assay of adenosine triphosphate. J Clin Microbiol (1975) 7.06
Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity (1998) 6.07
Transcription and processing of intervening sequences in yeast tRNA genes. Cell (1978) 5.07
Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science (1997) 4.86
Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain (2002) 4.05
Products of three accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudomonas aeruginosa pili. J Bacteriol (1990) 3.83
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet (1998) 3.76
Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature (1991) 3.74
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet (1999) 3.44
Cloning of yeast transfer RNA genes in Escherichia coli. Science (1977) 2.73
The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet (2001) 2.71
Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation (2001) 2.65
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res (2000) 2.39
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet (2004) 2.33
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol (1999) 2.20
Evaluation of acupuncture for pain control after oral surgery: a placebo-controlled trial. Arch Otolaryngol Head Neck Surg (1999) 2.12
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology (2000) 2.08
Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology (2005) 2.04
A clinical assessment of foetal diagnostic methods. J Obstet Gynaecol Br Commonw (1967) 2.02
The limb-girdle muscular dystrophies--proposal for a new nomenclature. Neuromuscul Disord (1995) 1.95
Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med (1999) 1.94
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology (2007) 1.80
Vacuoliting megalencephalic leukoencephalopathy with subcortical cysts, mapped to chromosome 22qtel. Am J Hum Genet (2000) 1.79
Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage (2006) 1.72
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum Mutat (2010) 1.67
Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J Med Genet (2005) 1.65
Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann Neurol (1999) 1.65
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet (1998) 1.64
Linguistics of nucleotide sequences: morphology and comparison of vocabularies. J Biomol Struct Dyn (1986) 1.63
Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis (1995) 1.61
Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry (2005) 1.60
The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature (1984) 1.58
Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet (1993) 1.58
Controlled trial of fetal intensive care. Am J Obstet Gynecol (1976) 1.57
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology (2000) 1.55
Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol (2011) 1.53
Post-traumatic stimulus suppressible myoclonus of peripheral origin. J Neurol Neurosurg Psychiatry (1998) 1.52
Detection of Chlamydia trachomatis in first-void urine collected from men and women attending a venereal clinic. APMIS (1991) 1.51
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry (2000) 1.49
In vitro transcription of a transfer RNA gene. Proc Natl Acad Sci U S A (1970) 1.47
Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol (1998) 1.47
ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer (2006) 1.47
A controlled trial of fetal heart rate monitoring in a low-risk obstetric population. Am J Obstet Gynecol (1981) 1.44
Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy. Neurology (2001) 1.44
A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet (1997) 1.44
An alpha-tectorin gene defect causes a newly identified autosomal recessive form of sensorineural pre-lingual non-syndromic deafness, DFNB21. Hum Mol Genet (1999) 1.44
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 1.44
Brain spect perfusion of frontotemporal dementia associated with motor neuron disease. Neurology (2007) 1.41
Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice. J Cell Biol (2000) 1.41
[Paroxysmal kinesigenic choreoathetosis: autonomic disease or reflex epilepsy?]. Rev Neurol (Paris) (1990) 1.39
[Idiopathic left ventricular aneurysm presenting with ventricular tachycardia. A case report]. Arch Mal Coeur Vaiss (2000) 1.38
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene (2009) 1.37
Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype. Eur Heart J (2001) 1.37
Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem (1998) 1.36
Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care (2000) 1.35
Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31
Severe childhood autosomal recessive muscular dystrophy with the deficiency of the 50 kDa dystrophin-associated glycoprotein maps to chromosome 13q12. Hum Mol Genet (1993) 1.31
Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol (1999) 1.31
Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). Brain (1998) 1.30
Pathological lesions in colonic biopsies during Parkinson's disease. Gut (2008) 1.29
Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology (2001) 1.28
2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features? J Med Genet (2008) 1.25
Genetic characterization of CHO production host DG44 and derivative recombinant cell lines. Biochem Biophys Res Commun (2005) 1.25
Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol (1998) 1.25
A homeobox gene, vax2, controls the patterning of the eye dorsoventral axis. Proc Natl Acad Sci U S A (1999) 1.24
Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am J Hum Genet (1992) 1.22
Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord (2000) 1.22
Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene. Am J Med Genet A (2010) 1.21
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology (2008) 1.21
A new dimension for the human genome project: towards comprehensive expression maps. Nat Genet (1997) 1.21
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry (2000) 1.21
Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. J Physiol (2002) 1.19
Efficacy of Chinese acupuncture on postoperative oral surgery pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 1.18
A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet (1995) 1.18
Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes. Hum Mol Genet (2000) 1.18
The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm. Neuroreport (1998) 1.18
Circadian regulation of islet genes involved in insulin production and secretion. Mol Cell Endocrinol (2004) 1.16
Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc Natl Acad Sci U S A (2002) 1.16
Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis (2011) 1.16
Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol (2000) 1.15
Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene. Ann Neurol (1991) 1.15
Effect of normally occurring rabbit antibodies on fluorescent-antibody reactions. J Bacteriol (1966) 1.15
How neutral are synonymous codon mutations? Nat Genet (1995) 1.14
Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology (2001) 1.13
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol (1995) 1.13